The board of directors of Everest Medicines Limited announced that Ms. Yin Yin (Ms. Yin) has tendered her resignation as a joint company secretary of the company with effect from January 31, 2022 due to personal reason.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.1 HKD | -2.64% | -6.95% | +5.74% |
05-14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
05-14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.74% | 931M | |
-2.95% | 90.75B | |
-1.97% | 39.03B | |
-15.47% | 31.85B | |
+62.42% | 26.26B | |
-22.81% | 14.13B | |
-8.82% | 12.87B | |
-11.77% | 11.6B | |
-45.97% | 10.91B | |
+3.22% | 8.89B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Everest Medicines Limited Announces Resignation of Ms. Yin Yin as Joint Company Secretary